Frequently Asked Questions

Ibogaine addresses addiction at the neurological root — resetting opioid receptors, upregulating GDNF (glial cell-derived neurotrophic factor), and repairing dopamine pathways in a single treatment session. Conventional approaches manage symptoms; ibogaine targets the underlying neurochemistry. Patients consistently report dramatic reduction or complete elimination of withdrawal symptoms and cravings within 24 hours, something no pharmaceutical therapy achieves.

Unlike psilocybin, ayahuasca, or ketamine, ibogaine has a unique dual mechanism: it is both a powerful psychedelic that facilitates deep psychological processing and a pharmacological reset for opioid, dopamine, and serotonin receptor systems. No other substance addresses both the psychological and neurochemical dimensions of addiction simultaneously. The experience typically lasts 12 to 24 hours, allowing profound introspection that shorter psychedelic sessions cannot match.

Yes. Peer-reviewed studies published in journals including the American Journal of Drug and Alcohol Abuse, Psychopharmacology, and the Journal of Psychoactive Drugs demonstrate ibogaine's efficacy for opioid dependence, with 50 to 80 percent sustained abstinence at 12-month follow-up. Research from institutions worldwide shows ibogaine promotes neuroplasticity through BDNF and GDNF upregulation — mechanisms now being studied for neurodegenerative conditions like Parkinson's disease.

MindScape combines the highest medical safety standards — board-certified physicians, continuous cardiac monitoring, comprehensive pre-screening — with a deeply personalized treatment experience. With over 900 patients treated and zero medical complications across 5 years, our safety record speaks for itself. We are one of the only clinics using both ibogaine HCL and Total Alkaloid (TA) extract, selecting the optimal form for each patient's condition.

MindScape treats a wide range of conditions including opioid addiction (heroin, fentanyl, methadone, suboxone), alcohol dependence, cocaine and stimulant addiction, PTSD and complex trauma, treatment-resistant depression, anxiety disorders, Parkinson's disease, and chronic pain. Each condition has a tailored treatment protocol designed by our medical team.

An ibogaine session typically lasts 12 to 24 hours. The first several hours involve vivid, rapid visionary imagery often described as a life review — patients report seeing pivotal moments from their past with extraordinary clarity. This gives way to a period of deep, calm introspection where profound emotional insights surface. Most patients describe the experience as demanding but profoundly purposeful. A physician monitors you throughout the entire process.

5-MeO-DMT produces a complete, temporary dissolution of ego — a state patients consistently describe as the most meaningful experience of their lives. The active phase lasts approximately 15 to 45 minutes, though the subjective experience often feels timeless. Many describe it as encountering a profound, boundaryless awareness that puts their life into perspective.

Our outcome data shows the vast majority of patients report sustained freedom from the patterns that brought them to us at twelve-month follow-up. Integration support significantly extends outcomes. No treatment guarantees permanence, but ibogaine's neurological mechanism — including GDNF upregulation and neural pathway reset — produces changes that pharmaceutical approaches simply cannot match.

Ibogaine HCL is a purified, semi-synthesized form of the primary alkaloid derived from Voacanga africana bark. Ibogaine TA (Total Alkaloid) extract retains all 12 natural alkaloids found in the Tabernanthe iboga root, delivering additional neuroprotective, anti-inflammatory, and emotionally restorative benefits. MindScape is one of the only centers to use both forms in its treatment protocols, selecting the optimal preparation for each patient's condition.

Both. Our framework integrates rigorous medical science — board-certified physicians, cardiac monitoring, evidence-based protocols — with reverence for the profound psychological and spiritual dimensions of psychedelic therapy. We believe the two are inseparable for lasting transformation.

Yes. We offer a specialized 14 to 18 day ibogaine microdosing program tailored for Parkinson's patients. This protocol promotes neuroregeneration, enhances dopamine pathways, and alleviates symptoms like tremors and rigidity. Emerging research on ibogaine's GDNF upregulation makes it particularly promising for neurodegenerative conditions.

Ibogaine carries real cardiac risks when administered without proper screening and oversight. At MindScape, every patient undergoes comprehensive cardiac evaluation including EKG, blood panel, and full medical history review before admission. A board-certified physician and trained nurse are present throughout every session with continuous cardiac monitoring. When administered with proper medical protocols, ibogaine has an excellent safety record. In over 900 patients and 5 years of operation, MindScape has had zero medical complications.

Certain medications must be discontinued before ibogaine treatment, particularly SSRIs, MAOIs, benzodiazepines, and certain cardiac medications. Our medical team provides a comprehensive pre-treatment protocol and guides you through safe tapering schedules. This is discussed thoroughly during your medical screening — we never ask patients to stop medications abruptly or unsafely.

Every patient completes a thorough medical evaluation including a 12-lead EKG, comprehensive blood panel, liver function tests, complete medical history review, and psychiatric assessment. Patients with certain cardiac conditions, severe liver disease, or contraindicated medications may not be candidates. Our medical team reviews everything before confirming eligibility.

Yes, always. A board-certified physician is on-site throughout every ibogaine session. You are continuously monitored with cardiac telemetry, blood pressure, and oxygen saturation equipment. Our nurse-to-patient ratio ensures individual attention throughout the entire 12 to 24 hour treatment window.

Yes. Ibogaine is unscheduled and fully legal in Mexico, which is precisely why world-class clinics operate here. MindScape Retreat operates fully within Mexican medical and regulatory frameworks, with licensed physicians on staff and all required medical permits.

No. Traveling to Mexico for ibogaine treatment is completely legal. Ibogaine is unscheduled in Mexico, and there are no legal consequences for seeking medical treatment abroad. Thousands of patients travel internationally for ibogaine therapy each year. We advise patients not to attempt to bring any substances back to their home country.

Program investment starts at $6,500 USD for a 5-day retreat and ranges up to $17,500 USD for an 18-day comprehensive protocol. All-inclusive pricing covers private accommodations, nutritious meals, complete medical supervision, individual and group therapy, daily wellness activities, excursions, and 90-day post-retreat integration support. Visit our Plans & Pricing page for detailed program options.

Most traditional insurance plans do not currently cover ibogaine treatment. However, some patients have had success using HSA/FSA funds, medical financing, or requesting out-of-network reimbursement. We provide detailed medical documentation that may support insurance claims. Many patients also find that the cost of ibogaine treatment is significantly less than years of conventional rehabilitation programs.

Cozumel has an international airport (CZM) with direct flights from Miami, Fort Lauderdale, Houston, Dallas, Charlotte, and other major US cities. You can also fly into Cancun (CUN) and take a short 45-minute ferry ride from Playa del Carmen. We provide complete travel guidance and arrange complimentary airport or ferry pickup for all patients.

All programs are fully all-inclusive: private room with full bath, nutritious chef-prepared meals, complete medical supervision, one-on-one and group therapy sessions, daily yoga and meditation, sound therapy, cold water immersion, Mayan sauna (temazcal), snorkeling tours, shore excursions, massage therapy, and 90-day post-retreat integration support with your assigned psychologist.

Absolutely — many of our patients arrive on their own. Our team provides complete on-the-ground support from the moment you land until departure. You will never feel alone. If you prefer to bring a trusted companion, we welcome guests and can arrange separate accommodation for them in Cozumel.

We recommend booking 2 to 4 weeks in advance to allow time for medical screening and pre-treatment preparation. However, we understand that some situations are urgent. Contact our team and we will do everything possible to accommodate your timeline.

Preparation begins during your medical screening. Our team will guide you through medication tapering (if applicable), dietary recommendations, and psychological preparation. We provide a comprehensive preparation guide covering what to bring, what to expect, and how to set intentions for your experience. Most patients describe the preparation process as the beginning of their healing journey.

Integration is where lasting change takes root. You leave with a structured 90-day integration plan, scheduled coaching sessions with your assigned psychologist, access to our private patient community, and practical tools for maintaining your transformation. Your psychologist remains available for follow-up sessions for up to six months post-retreat.

Published clinical literature reports that 50 to 80 percent of opioid-dependent patients treated with ibogaine remain abstinent at 12-month follow-up — far exceeding conventional treatment outcomes. MindScape's own patient data aligns with these figures. Success varies by condition, severity, and commitment to post-treatment integration. We share our outcome data transparently during consultation.

Yes. Some patients benefit from a second treatment, particularly those with complex or long-standing conditions. Typically we recommend waiting at least 3 to 6 months between treatments to allow the neurological changes to fully integrate. Our medical team will advise on whether a follow-up treatment is appropriate for your situation.